NCT05366010View on ClinicalTrials.gov

Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Disease (NMD) Patients

NATerminatedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

November 4, 2021

Primary Completion Date

February 27, 2024

Study Completion Date

February 27, 2024

Conditions

Neuromuscular Diseases

Interventions

DEVICE

Oscillation and Lung Expansion (OLE) therapy

Respiratory airway clearance intervention including continuous high-frequency oscillation and continuous positive expiratory pressure

Trial Locations (1)

27709

Science 37, Durham

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Science 37

INDUSTRY

lead

Baxter Healthcare Corporation

INDUSTRY